Literature DB >> 9092510

Evidence of proteasome-mediated cytochrome P-450 degradation.

B J Roberts1.   

Abstract

The cytochrome P-450 family of enzymes performs an incredibly diverse range of detoxification and oxidation reactions within the cell and constitutes between 5 and 10% of protein in hepatic endoplasmic reticulum. In this report it is demonstrated that constitutively expressed membranous P-450s are targeted for destruction by the proteasome, in a process which is ubiquitin-independent and is demonstrated in vitro to require prior labilization of the enzyme. This process was specific for P-450s CYP1A2, CYP2E1, CYP3A, and CYP4A and was not demonstrated to be involved in the turnover of CYP1A1, CYP2B1/2, or NADPH reductase. In reconstitution experiments using purified proteasomes and microsomal fractions, labilized P-450 conformations are protected from 20 S proteasome degradation by substrate addition, with proteolysis occurring while P-450s are still attached to the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092510     DOI: 10.1074/jbc.272.15.9771

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Turnover of matrix proteins in mammalian mitochondria.

Authors:  Walter Huth; Stefan Rolle; Ilona Wunderlich
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

2.  Ethanol induction of CYP2A5: permissive role for CYP2E1.

Authors:  Yongke Lu; Jian Zhuge; Defeng Wu; Arthur I Cederbaum
Journal:  Drug Metab Dispos       Date:  2010-11-04       Impact factor: 3.922

3.  Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: identification of sites targeted for phosphorylation and ubiquitination.

Authors:  YongQiang Wang; Shenheng Guan; Poulomi Acharya; Dennis R Koop; Yi Liu; Mingxiang Liao; Alma L Burlingame; Maria Almira Correia
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 4.  Membrane Protein Quantity Control at the Endoplasmic Reticulum.

Authors:  Ignat Printsev; Daniel Curiel; Kermit L Carraway
Journal:  J Membr Biol       Date:  2016-10-14       Impact factor: 1.843

Review 5.  Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.

Authors:  Sung-Mi Kim; YongQiang Wang; Noushin Nabavi; Yi Liu; Maria Almira Correia
Journal:  Drug Metab Rev       Date:  2016-06-20       Impact factor: 4.518

6.  Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance.

Authors:  Sung-Mi Kim; Poulomi Acharya; Juan C Engel; Maria Almira Correia
Journal:  J Biol Chem       Date:  2010-09-06       Impact factor: 5.157

7.  Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins.

Authors:  Choon-Myung Lee; Bong-Yoon Kim; Lian Li; Edward T Morgan
Journal:  J Biol Chem       Date:  2007-11-09       Impact factor: 5.157

8.  Assembly and intracellular localization of the bluetongue virus core protein VP3.

Authors:  Alak Kanti Kar; Nao Iwatani; Polly Roy
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 9.  CYP2E1 and oxidative liver injury by alcohol.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Free Radic Biol Med       Date:  2007-11-17       Impact factor: 7.376

Review 10.  Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.

Authors:  Magnus Ingelman-Sundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-22       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.